We are live on
!
Find out more
AIG
American International Group Portfolio holdings
AUM
$609M
1-Year Est. Return
23.67%
This Fund
S&P 500
This Quarter
Est. Return
+6.37%
1 Year Est. Return
-23.67%
3 Year Est. Return
+19.07%
5 Year Est. Return
+37.34%
10 Year Est. Return
+206.83%
AUM
$29.5M
AUM Growth
+$1.01M
(+3.6%)
Cap. Flow
-$541M
Cap. Flow
% of AUM
-1,831.18%
Top 10 Holdings %
Top 10 Hldgs %
18.03%
Holding
3,422
New
250
Increased
849
Reduced
1,936
Closed
318
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$131M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$50M |
| 3 |
Cullinan Oncology
CGEM
|
+$37.6M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$26.1M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles River Laboratories
CRL
|
+$24.9M |
| 2 |
JPMorgan Chase
JPM
|
+$23.6M |
| 3 |
Home Depot
HD
|
+$22.9M |
| 4 |
HP
HPQ
|
+$21.9M |
| 5 |
Apple
AAPL
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.02% |
| 2 | Healthcare | 13.11% |
| 3 | Consumer Discretionary | 10.59% |
| 4 | Financials | 10.33% |
| 5 | Industrials | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Invesco Mortgage Capital
IVR
$805M
| $641 | ﹤0.01% |
16,437
+967
| +6% | +$36.6K |
|
|
TBI
1777
Trueblue
TBI
$311M
| $640 | ﹤0.01% |
22,750
-674
| -3% | -$17.9K |
|
1778
Dillards
DDS
$9.56B
| $637 | ﹤0.01% |
3,521
-602
| -15% | -$77.6K |
|
1779
Marten Transport
MRTN
$1.22B
| $636 | ﹤0.01% |
38,580
-798
| -2% | -$13.6K |
|
1780
Donnelley Financial Solutions
DFIN
$1.16B
| $632 | ﹤0.01% |
19,159
-622
| -3% | -$18.5K |
|
|
INN
1781
Summit Hotel Properties
INN
$700M
| $631 | ﹤0.01% |
67,585
-1,470
| -2% | -$14.5K |
|
|
AMTI
1782
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $630 | ﹤0.01% |
13,777
+838
| +6% | +$39.6K |
|
1783
Pulmonx
LUNG
$87.6M
| $628 | ﹤0.01% |
14,231
+7,464
| +110% | +$325K |
|
1784
CoStar Group
CSGP
$12.3B
| $624 | ﹤0.01% |
7,530
-1,220
| -14% | -$105K |
|
1785
Andersons Inc
ANDE
$2.22B
| $623 | ﹤0.01% |
20,416
-318
| -2% | -$9.59K |
|
|
DFTX
1786
Definium Therapeutics
DFTX
$6.12B
| $623 | ﹤0.01% |
+12,031
| New | +$632K |
|
1787
Madrigal Pharmaceuticals
MDGL
$11.8B
| $620 | ﹤0.01% |
6,362
+1,263
| +25% | +$150K |
|
|
ANAT
1788
DELISTED
American National Group, Inc. Common Stock
ANAT
| $620 | ﹤0.01% |
4,177
+4,089
| +4,647% | +$547K |
|
|
HNGR
1789
DELISTED
Hanger Inc.
HNGR
| $618 | ﹤0.01% |
24,451
-296
| -1% | -$7.38K |
|
1790
MGP Ingredients
MGPI
$375M
| $617 | ﹤0.01% |
9,115
+500
| +6% | +$32.8K |
|
|
RUBY
1791
DELISTED
Rubius Therapeutics, Inc
RUBY
| $617 | ﹤0.01% |
25,263
+4,374
| +21% | +$109K |
|
1792
Huron Consulting
HURN
$2.42B
| $616 | ﹤0.01% |
12,529
-672
| -5% | -$36.1K |
|
|
VIVO
1793
DELISTED
Meridian Bioscience Inc
VIVO
| $616 | ﹤0.01% |
27,752
-510
| -2% | -$10.8K |
|
1794
BioLife Solutions
BLFS
$1.7B
| $609 | ﹤0.01% |
13,678
+5,482
| +67% | +$193K |
|
1795
Ocular Therapeutix
OCUL
$2.02B
| $609 | ﹤0.01% |
42,952
+473
| +1% | +$7.19K |
|
|
WOW
1796
DELISTED
WideOpenWest
WOW
| $608 | ﹤0.01% |
29,374
-1,120
| -4% | -$17.6K |
|
|
DBD
1797
DELISTED
Diebold Nixdorf Incorporated
DBD
| $607 | ﹤0.01% |
47,288
-122
| -0.3% | -$1.67K |
|
|
AGEN
1798
Agenus
AGEN
$290M
| $606 | ﹤0.01% |
5,628
+958
| +21% | +$71.8K |
|
1799
Globalstar
GSAT
$10.8B
| $606 | ﹤0.01% |
+22,680
| New | +$445K |
|
1800
Genesco
GCO
$422M
| $604 | ﹤0.01% |
9,481
-132
| -1% | -$7.16K |
|
Similar funds
SAM
DCM
PL
OWM
PM
NFSG
MA
FFWA
American International Group's Q2 2021 Portfolio in Review
As of Q2 2021, American International Group held 3,422 positions worth $29.5M, up 3.6% from $28.5M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
American International Group withdrew a net $541M in Q2 2021, closing 318 positions and reducing 1,936 holdings. Its most notable exit was PRA Health Sciences, Inc., an estimated $18K position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, American International Group opened a new position in iShares Core S&P 500 ETF worth $135K.
- American International Group's largest Q2 2021 buy was iShares Core S&P 500 ETF: 313,300 shares worth $135K.
- American International Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $50M increase.
- American International Group's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $24.9M.
- American International Group fully exited PRA Health Sciences, Inc. in Q2 2021, selling an estimated $18K.
- American International Group's ten largest holdings make up 18% of its $29.5M portfolio in Q2 2021.
- American International Group opened 250 new positions and closed 318 in Q2 2021.
- American International Group's portfolio value rose 3.6% quarter-over-quarter to $29.5M.
Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.